All News
Filter News
Found 71 articles
-
Alexza Pharmaceuticals, Inc. Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
4/29/2008
-
Alexza Pharmaceuticals, Inc. Secures $50 Million Committed Equity Financing Facility
4/1/2008
-
Alexza Pharmaceuticals, Inc. Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore
3/27/2008
-
Alexza Pharmaceuticals, Inc. Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
3/18/2008
-
Alexza Pharmaceuticals, Inc. to Announce 2007 Financial Results
3/12/2008
-
Alexza Pharmaceuticals, Inc. Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
2/25/2008
-
Alexza Pharmaceuticals, Inc. Announces Partnership With Endo Pharmaceuticals for AZ-003 in North America; Alexza Will Receive $10M Up Front and Future Payments of Up to $40M
12/28/2007
-
Alexza Pharmaceuticals, Inc. Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients Initial Results Expected to be Reported in Q1 2008
12/18/2007
-
Alexza Pharmaceuticals, Inc. Reports Third Quarter Financial Results and Updates Development of Product Candidates
11/2/2007
-
Alexza Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 1, 2007
10/25/2007
-
The 4th Annual Biotechnology Industry Organization (BIO) Investor Forum to Webcast Alexza Pharmaceuticals, Inc.'s Corporate Presentation
10/4/2007
-
Alexza Pharmaceuticals, Inc. to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
9/19/2007
-
Alexza Pharmaceuticals, Inc. Reports Second Quarter Financial Results and Updates Development of Product Candidates
8/14/2007
-
Alexza Pharmaceuticals, Inc. to Announce Second Quarter 2007 Financial Results on August 13, 2007
8/7/2007
-
Nasrat Hakim Joins Alexza Pharmaceuticals, Inc. as Vice President, Quality
7/19/2007
-
Alexza Pharmaceuticals, Inc. Selected to Join Russell 3000(R) Index
6/22/2007
-
Alexza Pharmaceuticals, Inc. Expands Staccato(R) Migraine Product Portfolio
6/20/2007
-
Piper Jaffray Second Annual London Health Care Conference to Webcast Piper Jaffray's Corporate Presentation
6/15/2007
-
Piper Jaffray to Host 2nd Annual London Health Care Conference
6/13/2007
-
Alexza Pharmaceuticals, Inc. to Present AZ-004 (Staccato(R) Loxapine) Clinical Data at the Annual NCDEU Meeting
6/5/2007